Health
Johnson & Johnson COVID-19 vaccine linked to potentially paralysing Guillain-Barré syndrome – 7NEWS.com.au
Just weeks ago, the TGA granted the vaccine provisional approval for use in Australia.
There are fears some recipients of Johnson & Johnsons coronavirus vaccine face an increased risk of a rare neurological complication known as Guillain-Barre syndrome (GBS) after an increase in reports of the sometimes paralysing condition.
The US Food and…
Continue Reading
-
General18 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General22 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General21 hours agoJaguar Land Rover in UK pauses shipments to US
-
General17 hours agoAustralian share market set to dive as threat of US recession grows